pRxEngage

Startup

pRxTrialPort is an AI-first, human-centred platform built to help patients become partners in research.

In rare disease and oncology, too many people are still expected to navigate complexity, jargon, and life-changing decisions with far too little clarity. We are changing that. By combining AI at the core of the platform with decades of expertise across biotech, pharma, CRO, and technology, pRxTrialPort helps deliver faster, higher-quality, and more scalable support for patients, caregivers, community groups, sponsors, and sites.

This is not AI as decoration. It is AI as infrastructure.

And because it is guided by real domain expertise, it allows us to do what others often cannot do well at the same time: move quickly, keep quality high, reduce cost, and stay deeply human.

Meet us at World Orphan Drug Congress Boston 2026 if you care about a future where patients have more agency, decisions are more shared, and innovation actually helps people navigate the journey rather than just admire the map.

website